- Novo faces pressure from compounded dr-gs and rival Eli Lilly
- CFO doesn't expect reduction in compounded dr-gs this year
- Novo expands direct-to-consumer platform amid pricing challenges
- Several analysts cut price target on stock since last week
- Outgoing CEO warns may be hard to avoid layoffs
https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-ceo-warns-layoffs-wegovy-challenge-heats-up-2025-08-06/
There are no replies in this thread yet. Be the first to post a reply below: